Exova Group PLC Director/PDMR Shareholding (3911Q)
29 November 2016 - 8:00PM
UK Regulatory
TIDMEXO
RNS Number : 3911Q
Exova Group PLC
29 November 2016
EXOVA GROUP PLC
Notification of transactions of Directors and PDMRs
On 28 November 2016, Paul Barry, a person discharging managerial
responsibilities ("PDMR"), sold 29,389 ordinary shares of 1 pence
each ("Shares") in Exova Group plc (the "Company") as set out in
column 3 in order to discharge tax liabilities arising upon
exercise of a bonus share award as set out in the Company's RNS
announcement dated 24 November 2016.
1. Name 2. Status 3. Number of Shares sold
and price per Share
----------- ---------- ----------------------------
Paul Barry PDMR 29,389 at GBP1.84 per Share
----------- ---------- ----------------------------
Following the sale, Paul Barry's total shareholding in the
capital of Exova Group plc is 60,511 ordinary shares, representing
0.02 per cent. of the voting share capital of Exova Group plc.
1 Details of the person discharging managerial
responsibilities/person closely associated
---- ---------------------------------------------------------------------
a) Name Paul Barry
---- ---------------------------- ---------------------------------------
2 Reason for the notification
---- ---------------------------------------------------------------------
a) Position/status PDMR - Group Managing Director,
Industries
---- ---------------------------- ---------------------------------------
b) Initial notification Initial notification
/ Amendment
---- ---------------------------- ---------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ---------------------------------------------------------------------
a) Name Exova Group plc
---- ---------------------------- ---------------------------------------
b) LEI N/A
---- ---------------------------- ---------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ---------------------------------------------------------------------
a) Description Ordinary shares of 1p each
of the financial
instrument,
type of instrument
GB00BKY7HG11
Identification
code
---- ---------------------------- ---------------------------------------
b) Nature of Sale of shares in order to discharge
the transaction tax liabilities arising upon
exercise of a bonus share award
as set out in the Company's
RNS announcement dated 24 November
2016.
---- ---------------------------- ---------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s)
---- ---------------------------- ------------------ -------------------
1.84 29,389
--------------------------------- ------------------ -------------------
d) Aggregated
information
- Aggregated N/A
volume
- Price
---- ---------------------------- ---------------------------------------
e) Date of the 28 November 2016
transaction
---- ---------------------------- ---------------------------------------
f) Place of the London
transaction
---- ---------------------------- ---------------------------------------
This notification is made in accordance with Article 19 of the
Market Abuse Regulation and the Disclosure and Transparency
Rules.
For and on behalf of Exova Group plc
Date: 29 November 2016
Neil MacLennan
General Counsel & Company Secretary
Telephone: 0131 333 8053
About Exova
Exova is one of the world's leading laboratory-based testing
groups, trusted by organisations to test and advise on the safety,
quality and performance of their products and operations.
Headquartered in Edinburgh, UK, Exova operates 138 laboratories and
offices in 33 countries and employs more than 4,300 people
throughout Europe, the Americas, the Middle East, Asia/Asia Pacific
and Africa.
Exova's capabilities help to extend asset life, bring
predictability to applications, and shorten the time to market for
customers' products, processes and materials. With over 90 years'
experience, Exova specialises in testing across a number of key
sectors ranging from Aerospace to Fire & Building Products; Oil
& Gas and Industrials; Infrastructure & Environment;
Automotive; and Health Sciences.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUKONRNNAAURA
(END) Dow Jones Newswires
November 29, 2016 04:00 ET (09:00 GMT)
Exova (LSE:EXO)
Historical Stock Chart
From Apr 2024 to May 2024
Exova (LSE:EXO)
Historical Stock Chart
From May 2023 to May 2024
